Clin2
NCT07033091Likely a fitRecruiting

HPV screening study for healthy adults 40 and older

Oropharynx Cancer

Treatments studied

Part of Cancer, Ear, nose & throat, Infections, Mouth & dental clinical trials.

This study checks healthy adults aged 40+ for HPV in the mouth using a simple gargle rinse. It aims to see if this can help find early signs of oropharyngeal cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20,000 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You are 40 years old or older.
  • You can rinse your mouth by gargling on your own.
  • You agree to sign a consent form for the study and genetic testing.
  • You have never been diagnosed with head or neck cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05307939Recruiting· Phase 2
Using tumor DNA tests to time treatment for HPV throat cancer

This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.

Miami, Florida
NCT06305676Recruiting
A study for early detection of HPV throat cancer

This study looks for early signs of HPV-related throat cancer. If you've just been diagnosed and haven't started treatment, your blood or saliva samples may help improve future screening tests.

Tampa, Florida
NCT06528353Not yet recruiting
Blood test screening for HPV-related throat cancer

This study is looking for men aged 50 and older to take a simple blood test that may help detect early signs of throat cancer caused by HPV. The goal is to find out if this blood-based screening could catch the cancer sooner.

NCT04564989Recruiting
Biomarker study for HPV-related throat cancer outcomes

This observational study checks how well a blood test for HPV DNA (and other tumor genetic markers) predicts outcomes in certain throat cancers. It may help doctors better track the disease and plan treatment, because the trial validates these lab signals against real-world results.

Rochester, Minnesota
NCT05649865Recruiting
Monitor HPV DNA in throat cancer to guide early response

This study checks a substance called HPV DNA in your blood to see how your HPV-positive throat cancer responds early during treatment. It may help doctors spot who is responding well and who may need closer attention sooner.

Lund, Skåne County
NCT06115772Recruiting
HPV and genital health in women with HPV-positive throat cancer

This study looks at HPV-related health in the genital and anal areas of women who have HPV-positive oropharyngeal cancer, or are the female partners of someone who does. The goal is to better understand how HPV affects these areas over time.

Rochester, Minnesota

Hear when a new Oropharynx Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.